Norepinephrine Retains Its Vasopressor Effect in Metabolic Acidosis
Norepinephrine remains effective and should be used as the first-line vasopressor in patients with hypotension due to metabolic acidosis, as current evidence shows it maintains its vasopressor properties even in severe acidosis. 1, 2
The Evidence on Norepinephrine and Acidosis
Clinical Guidelines Are Clear
The 2017 Surviving Sepsis Campaign guidelines strongly recommend norepinephrine as the first-choice vasopressor regardless of acid-base status 2. This recommendation holds even when metabolic acidosis is present, as the guidelines do not exclude acidotic patients from standard vasopressor therapy.
What the Research Actually Shows
The concern about norepinephrine "not working" in acidosis is largely outdated and not supported by modern evidence:
Human arterial studies demonstrate preserved function: A 2014 study examining human internal mammary arteries found that decreasing pH from 7.40 down to 6.80 did not significantly impair the potency or efficacy of norepinephrine 3. This is critical—the drug works even at pH 6.80, which is profoundly acidotic.
The old teaching is wrong: While a 1958 study suggested reduced responsiveness 4, this was based on limited observations and has been contradicted by more rigorous modern research.
Receptor-specific effects matter: Acidosis may selectively reduce α2-adrenoceptor responses 5, but norepinephrine primarily acts through α1-adrenoceptors for its vasopressor effect, which remain functional in acidosis 3.
Critical Clinical Caveats
Don't Mix with Alkaline Solutions
Adrenergic drugs should never be mixed with sodium bicarbonate or other alkaline solutions in the IV line, as catecholamines are inactivated in alkaline solutions 1. This is a common pitfall—if you're giving bicarbonate to correct acidosis, use a separate IV line.
The Real Problem Isn't the Drug—It's the Underlying Pathophysiology
When patients appear "resistant" to norepinephrine in metabolic acidosis, the issue is typically:
- Uncorrected hypovolemia (norepinephrine is relatively contraindicated in hypovolemia) 1
- Severe vasodilation from the underlying disease (sepsis, shock)
- Inadequate source control in septic patients 6
Dosing Considerations
- Start at 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70-kg adult) 1
- Target MAP ≥65 mmHg 2, 7
- Titrate to effect—some patients may require very high doses 8
- If inadequate response at moderate doses (0.1-0.2 mcg/kg/min), add vasopressin 0.03 units/min rather than abandoning norepinephrine 2, 9
The Bicarbonate Question
The administration of bicarbonate to improve vasopressor responsiveness is NOT recommended unless pH <7.15 10, 6. The 2016 Surviving Sepsis guidelines and surgical emergency guidelines agree that alkalinizing agents should only be used in severe acidosis (pH <7.15) when there is catecholamine receptor resistance-induced hypotension 10.
Practical Algorithm
Ensure adequate volume resuscitation first—this is the most common reason for apparent vasopressor "failure" 1, 8
Start norepinephrine at standard doses regardless of pH 2
If pH <7.15 AND hypotension persists despite adequate fluid resuscitation and moderate-dose norepinephrine, consider bicarbonate therapy 10, 6
If inadequate response to norepinephrine alone, add vasopressin (up to 0.03 U/min) or epinephrine as second-line agents 2
Address the underlying cause of acidosis (source control in sepsis, tissue perfusion, etc.) 6
Why This Matters for Mortality
Metabolic acidosis itself is associated with increased mortality and post-intubation hypotension 11, but this reflects the severity of the underlying disease process rather than drug ineffectiveness. Delaying or withholding norepinephrine while attempting to correct acidosis first can worsen outcomes by prolonging hypotension and organ hypoperfusion 10.
The key is recognizing that norepinephrine works in acidosis—you just need to use it appropriately with adequate volume resuscitation and address the underlying pathology simultaneously.